Texas Instruments (NasdaqGS:TXN) Reports Q1 Earnings Growth And Positive Q2 Revenue Guidance

Simply Wall St.
25 Apr

Texas Instruments announced its Q1 2025 earnings on April 23, reporting sales of $4.069 billion, a rise from $3.661 billion year-over-year, and net income of $1.179 billion, up from $1.105 billion. The same day, the company provided revenue guidance for Q2 between $4.17 billion and $4.53 billion. These earnings results and positive future guidance may have contributed to its 2.5% price increase over the last week. With chipmakers leading a tech rally and broader markets rising by 2.3%, Texas Instruments' performance aligned closely with these market trends, further reinforcing its stock's upward movement.

You should learn about the 1 possible red flag we've spotted with Texas Instruments.

NasdaqGS:TXN Revenue & Expenses Breakdown as at Apr 2025

The end of cancer? These 23 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

The recent Q1 2025 earnings report from Texas Instruments, showing sales of US$4.07 billion and a net income rise to US$1.18 billion, suggests a favorable short-term outlook. The positive revenue guidance for Q2 may bolster investor confidence, potentially stabilizing or enhancing the company's revenue and earnings forecasts. This could mitigate concerns over revenue pressures in key markets like automotive and industrial sectors, where the company faces underutilization and elevated inventory challenges. However, the longer-term focus remains on managing these pressures effectively.

Over the past five years, Texas Instruments has delivered a total shareholder return of 50.68%, showcasing substantial growth. This contrasts with its recent underperformance against the US market, which returned 5.9% over the past year, and the US Semiconductor industry, which gained 5.1%. This highlights the importance of balancing short-term gains with long-term strategic planning and execution.

The 2.5% weekly price increase following the earnings announcement should be viewed in light of the analyst price target of US$193.60, reflecting that the stock is currently trading at a slight discount to this target. With a current price of US$169.5, the mindset of analysts leans towards the stock being fairly priced, aligning with the more bearish expectations on Texas Instruments' future valuation and market conditions. This positions the stock within a competitive, albeit cautious, outlook for any potential market developments impacting revenue and earnings growth in the upcoming quarters.

Assess Texas Instruments' future earnings estimates with our detailed growth reports.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NasdaqGS:TXN.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10